Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18)

被引：23

作者：

Kissling, Esther ^{[1
]}

Pozo, Francisco ^{[2
]}

Buda, Silke ^{[3
]}

Vilcu, Ana-Maria ^{[4
]}

Rizzo, Caterina ^{[5
,6
]}

Gherasim, Alin ^{[7
,8
]}

Horvath, Judit Krisztina ^{[9
]}

Brytting, Mia ^{[10
]}

Domegan, Lisa ^{[11
]}

Meijer, Adam ^{[12
]}

Paradowska-Stankiewicz, Iwona ^{[13
]}

Machado, Ausenda ^{[14
]}

Vucina, Vesna Visekruna ^{[15
]}

Lazar, Mihaela ^{[16
]}

Johansen, Kari ^{[17
]}

Durrwald, Ralf ^{[18
]}

van der Werf, Sylvie ^{[19
,20
]}

Bella, Antonino ^{[5
]}

Larrauri, Amparo ^{[7
,8
]}

Ferenczi, Annamaria ^{[9
]}

Zakikhany, Katherina ^{[10
]}

O'Donnell, Joan ^{[11
]}

Dijkstra, Frederika ^{[12
]}

Bogusz, Joanna ^{[13
]}

Guiomar, Raquel ^{[21
]}

Filipovic, Sanja Kurecic ^{[15
]}

Pitigoi, Daniela ^{[22
]}

Penttinen, Pasi ^{[17
]}

Valenciano, Marta ^{[1
]}

机构：

[1] Epiconcept, Epidemiol Dept, 47 Rue Charenton, F-75012 Paris, France

[2] Inst Hlth Carlos III, WHO Natl Influenza Ctr, Natl Ctr Microbiol, Natl Influenza Reference Lab, Madrid, Spain

[3] Robert Koch Inst, Dept Infect Dis Epidemiol, Resp Infect Unit, Seestr 10, D-13353 Berlin, Germany

[4] Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ IPLESP U, F-75012 Paris, France

[5] Natl Inst Hlth, Dept Infect Dis, Rome, Italy

[6] Bambino Gesu Pediat Hosp, Rome, Italy

[7] Inst Hlth Carlos III, Natl Epidemiol Ctr, Madrid, Spain

[8] Inst Hlth Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

[9] Off Chief Med Officer, Budapest, Hungary

[10] Publ Hlth Agcy Sweden, Stockholm, Sweden

[11] Hlth Serv Execut Hlth Protect Surveillance Ctr, 25-27 Middle Gardiner St, Dublin D01 A4A3 1, Ireland

[12] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands

[13] Natl Inst Hyg, Natl Inst Publ Hlth, Warsaw, Poland

[14] Inst Nacl Saude Dr Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal

[15] Croatian Inst Publ Hlth, Zagreb, Croatia

[16] Cantacuzino Natl Med Mil Inst Res & Dev, Bucharest, Romania

[17] European Ctr Dis Prevent & Control ECDC, Gustav III S Blvd 40, S-16973 Solna, Sweden

[18] Natl Reference Ctr Influenza, Robert Koch Inst, Seestr 10, D-13353 Berlin, Germany

[19] Univ Paris Diderot SPC, Unit Genet Mol Virus ARN, Inst Pasteur, CNRS UMR3569, Paris, France

[20] Inst Pasteur, WHO Natl Influenza Ctr, CNR Virus Infect Resp, Paris, France

[21] Inst Nacl Saude Dr Ricardo Jorge, Dept Doencas Infeciosas, Lisbon, Portugal

[22] Carol Davila Univ Med & Pharm, Bucharest, Romania

来源：

VACCINE: X | 2019年 / 3卷

基金：

欧盟地平线“2020”;

关键词：

Influenza; Influenza vaccine; Vaccine effectiveness; Multicentre study; Case-control study; Europe; I-MOVE; ANTIBODY; BINDING; VIRUSES;

D O I：

10.1016/j.jvacx.2019.100042

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Introduction: Influenza A(H3N2) viruses predominated in Europe in 2016-17. In 2017-18 A(H3N2) and A(H1N1)pdm09 viruses co-circulated. The A(H3N2) vaccine component was the same in both seasons; while the A(H1N1)pdm09 component changed in 2017-18. In both seasons, vaccine seed A(H3N2) viruses developed adaptations/alterations during propagation in eggs, impacting antigenicity. Methods: We used the test-negative design in a multicentre primary care case-control study in 12 European countries to measure 2016-17 and 2017-18 influenza vaccine effectiveness (VE) against laboratory-confirmed influenza A(H1N1)pdm09 and A(H3N2) overall and by age group. Results: During the 2017-18 season, the overall VE against influenza A(H1N1)pdm09 was 59% (95% CI: 47-69). Among those aged 0-14, 15-64 and >= 65 years, VE against A(H1N1)pdm09 was 64% (95% CI: 37-79), 50% (95% CI: 28-66) and 66% (95% CI: 42-80), respectively. Overall VE against influenza A(H3N2) was 28% (95% CI: 17-38) in 2016-17 and 13% (95% CI: -15 to 34) in 2017-18. Among 0-14-year-olds VE against A(H3N2) was 28% (95%CI: -10 to 53) and 29% (95% CI: -87 to 73), among 15-64-year-olds 34% (95% CI: 18-46) and 33% (95% CI: -3 to 56) and among those aged >= 65 years 15% (95% CI: -10 to 34) and -9% (95% CI: -74 to 32) in 2016-17 and 2017-18, respectively. Conclusions: Our study suggests the new A(H1N1)pdm09 vaccine component conferred good protection against circulating strains, while VE against A(H3N2) was <35% in 2016-17 and 2017-18. The egg propagation derived antigenic mismatch of the vaccine seed virus with circulating strains may have contributed to this low effectiveness. A(H3N2) seed viruses for vaccines in subsequent seasons may be subject to the same adaptations; in years with lower than expected VE, recommendations of preventive measures other than vaccination should be given in a timely manner. (C) 2019 The Authors. Published by Elsevier Ltd.

引用

页数：10

共 50 条

[1] A(H1N1) pdm09 influenza infection: vaccine inefficiency
Friedman, Nehemya
Drori, Yaron
Pando, Rakefet
Glatman-Freedman, Aharona
Sefty, Hanna
Bassal, Ravit
Stein, Yaniv
Shohat, Tamy
Mendelson, Ella
Hindiyeh, Musa
Mandelboim, Michal
[J]. ONCOTARGET, 2017, 8 (20) : 32856 - 32863
[2] Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
Gefenaite, Giedre
Tacken, Margot
Bos, Jens
Stirbu-Wagner, Irina
Korevaar, Joke C.
Stolk, Ronald P.
Wolters, Bert
Bijl, Marc
Postma, Maarten J.
Wilschut, Jan
Nichol, Kristin L.
Hak, Eelko
[J]. PLOS ONE, 2013, 8 (06):
[3] 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals
Rondy, M.
Launay, O.
Puig-Barbera, J.
Gefenaite, G.
Castilla, J.
Donati, K. de Gaetano
Galtier, F.
Hak, E.
Guevara, M.
Costanzo, S.
Moren, A.
[J]. EUROSURVEILLANCE, 2015, 20 (02) : 9 - 20
[4] Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy
Bellino, Stefania
Bella, Antonino
Puzelli, Simona
Di Martino, Angela
Facchini, Marzia
Punzo, Ornella
Pezzotti, Patrizio
Castrucci, Maria Rita
Di Mario, Giuseppina
Calzoletti, Laura
Fabiani, Concetta
Chironna, Maria
Germinario, Cinzia
Tramuto, Fabio
Di Carlo, Vittorio
Affanni, Paola
Pascucci, Maria Grazia
D'Agaro, Pierlanfranco
Gallo, Tolinda
Pagani, Elisabetta
Natter, Bernhard
Camilloni, Barbara
Tosti, Anna
Pariani, Elena
Senatore, Sabrina
Serra, Caterina
Tanchis, Pierina Rita
Ghisetti, Valeria
Tiberti, Donatella
Romano, Lucio
Volpe, Enrico
Giannecchini, Simone
[J]. EXPERT REVIEW OF VACCINES, 2019, 18 (11) : 1201 - 1209
[5] Fetal Safety of an Adjuvanted Influenza A(H1N1)pdm09 Vaccine
Molgaard-Nielsen, Ditte
Pasternak, Bjorn
Svanstrom, Henrik
Krause, Tyra G.
Emborg, Hanne-Dorthe
Melbye, Mads
Hviid, Anders
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 392 - 392
[6] Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China
Zhang, Li
van der Hoek, Wim
Krafft, Thomas
Pilot, Eva
van Astenc, Liselotte
Lin, Ge
Wu, Shuangsheng
Duan, Wei
Yang, Peng
Wang, Quanyi
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (04) : 816 - 822
[7] Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children
Ortqvist, Ake
Bennet, Rutger
Hamrin, Johan
Rinder, Malin Ryd
Lindblad, Hans
Ohd, Joanna Nederby
Eriksson, Margareta
[J]. VACCINE, 2015, 33 (22) : 2558 - 2561
[8] Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016
Chambers, C.
Skowronski, D. M.
Sabaiduc, S.
Winter, A. L.
Dickinson, J. A.
De Serres, G.
Gubbay, J. B.
Drews, S. J.
Martineau, C.
Eshaghi, A.
Krajden, M.
Bastien, N.
Li, Y.
[J]. EUROSURVEILLANCE, 2016, 21 (11): : 27 - 34
[9] Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza
Ortqvist, Ake
Bennet, Rutger
Rinder, Malin Ryd
Lindblad, Hans
Eriksson, Margareta
[J]. VACCINE, 2012, 30 (39) : 5699 - 5702
[10] Moderate Vaccine Effectiveness against Severe Acute Respiratory Infection Caused by A(H1N1)pdm09 Influenza Virus and No Effectiveness against A(H3N2) Influenza Virus in the 2018/2019 Season in Italy
Rizzo, Caterina
Gesualdo, Francesco
Loconsole, Daniela
Pandolfi, Elisabetta
Bella, Antonino
Orsi, Andrea
Guarona, Giulia
Panatto, Donatella
Icardi, Giancarlo
Napoli, Christian
Orsi, Giovanni Battista
Manini, Ilaria
Montomoli, Emanuele
Campagna, Ilaria
Russo, Luisa
Alfonsi, Valeria
Puzelli, Simona
Reale, Antonino
Raucci, Umberto
Piccioni, Livia
Concato, Carlo
Degli Atti, Marta Luisa Ciofi
Villani, Alberto
Chironna, Maria
Tozzi, Alberto Eugenio
[J]. VACCINES, 2020, 8 (03) : 1 - 10

← 1 2 3 4 5 →